Pfizer Return on Investment 1986-2025 | PFE
Current and historical return on investment (ROI) values for Pfizer (PFE) over the last 10 years.
| Pfizer ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2025-06-30 |
$14.83B |
$146.51B |
10.03% |
| 2025-03-31 |
$12.05B |
$148.28B |
8.16% |
| 2024-12-31 |
$12.41B |
$145.90B |
8.33% |
| 2024-09-30 |
$5.78B |
$150.56B |
3.85% |
| 2024-06-30 |
$-2.35B |
$145.48B |
-1.55% |
| 2024-03-31 |
$-1.16B |
$153.87B |
-0.75% |
| 2023-12-31 |
$1.28B |
$150.83B |
0.85% |
| 2023-09-30 |
$10.79B |
$158.25B |
7.44% |
| 2023-06-30 |
$22.91B |
$160.65B |
16.72% |
| 2023-03-31 |
$32.93B |
$132.94B |
25.88% |
| 2022-12-31 |
$35.79B |
$128.80B |
28.95% |
| 2022-09-30 |
$33.55B |
$125.52B |
28.00% |
| 2022-06-30 |
$30.76B |
$121.76B |
26.40% |
| 2022-03-31 |
$24.15B |
$118.34B |
21.47% |
| 2021-12-31 |
$19.43B |
$113.66B |
17.84% |
| 2021-09-30 |
$17.15B |
$112.22B |
16.22% |
| 2021-06-30 |
$13.45B |
$105.67B |
12.63% |
| 2021-03-31 |
$9.91B |
$104.21B |
9.11% |
| 2020-12-31 |
$8.25B |
$100.61B |
7.63% |
| 2020-09-30 |
$2.62B |
$115.28B |
2.43% |
| 2020-06-30 |
$3.13B |
$115.09B |
3.00% |
| 2020-03-31 |
$5.32B |
$101.62B |
5.34% |
| 2019-12-31 |
$6.71B |
$99.40B |
6.85% |
| 2019-09-30 |
$5.62B |
$101.44B |
5.78% |
| 2019-06-30 |
$6.43B |
$96.09B |
6.54% |
| 2019-03-31 |
$6.14B |
$94.89B |
6.20% |
| 2018-12-31 |
$5.67B |
$96.67B |
5.62% |
| 2018-09-30 |
$14.00B |
$105.32B |
13.59% |
| 2018-06-30 |
$13.90B |
$99.06B |
13.82% |
| 2018-03-31 |
$13.66B |
$102.37B |
13.80% |
| 2017-12-31 |
$13.72B |
$105.19B |
14.12% |
| 2017-09-30 |
$13.17B |
$95.61B |
14.06% |
| 2017-06-30 |
$12.53B |
$92.89B |
13.43% |
| 2017-03-31 |
$12.26B |
$95.08B |
13.12% |
| 2016-12-31 |
$12.15B |
$91.24B |
13.13% |
| 2016-09-30 |
$12.22B |
$94.04B |
13.13% |
| 2016-06-30 |
$12.56B |
$93.52B |
13.41% |
| 2016-03-31 |
$12.68B |
$91.17B |
13.52% |
| 2015-12-31 |
$11.82B |
$93.74B |
12.42% |
| 2015-09-30 |
$12.14B |
$96.20B |
12.44% |
| 2015-06-30 |
$12.46B |
$93.91B |
12.34% |
| 2015-03-31 |
$12.82B |
$96.96B |
12.23% |
| 2014-12-31 |
$13.25B |
$103.16B |
12.38% |
| 2014-09-30 |
$14.15B |
$109.97B |
13.10% |
| 2014-06-30 |
$14.45B |
$109.22B |
13.37% |
| 2014-03-31 |
$14.78B |
$105.72B |
13.64% |
| 2013-12-31 |
$15.18B |
$107.08B |
13.74% |
| 2013-09-30 |
$14.70B |
$110.17B |
13.13% |
| 2013-06-30 |
$14.46B |
$110.51B |
12.83% |
| 2013-03-31 |
$15.04B |
$114.31B |
13.34% |
| 2012-12-31 |
$15.26B |
$112.71B |
13.45% |
| 2012-09-30 |
$14.62B |
$113.20B |
12.74% |
| 2012-06-30 |
$14.96B |
$110.83B |
12.69% |
| 2012-03-31 |
$14.12B |
$117.22B |
11.63% |
| 2011-12-31 |
$13.97B |
$117.55B |
11.31% |
| 2011-09-30 |
$13.94B |
$125.93B |
11.08% |
| 2011-06-30 |
$13.62B |
$124.69B |
10.80% |
| 2011-03-31 |
$13.80B |
$125.84B |
10.94% |
| 2010-12-31 |
$13.41B |
$126.68B |
10.59% |
| 2010-09-30 |
$11.49B |
$127.08B |
8.94% |
| 2010-06-30 |
$11.85B |
$124.64B |
9.77% |
| 2010-03-31 |
$10.77B |
$128.36B |
9.46% |
| 2009-12-31 |
$10.96B |
$133.64B |
10.72% |
| 2009-09-30 |
$13.43B |
$98.65B |
15.76% |
| 2009-06-30 |
$12.75B |
$95.10B |
16.09% |
| 2009-03-31 |
$12.25B |
$81.51B |
16.58% |
| 2008-12-31 |
$11.73B |
$65.70B |
16.20% |
| 2008-09-30 |
$11.65B |
$74.49B |
15.73% |
| 2008-06-30 |
$8.58B |
$73.82B |
11.66% |
| 2008-03-31 |
$7.09B |
$75.56B |
9.64% |
| 2007-12-31 |
$7.52B |
$72.32B |
10.16% |
| 2007-09-30 |
$6.93B |
$72.65B |
9.21% |
| 2007-06-30 |
$10.17B |
$73.87B |
13.41% |
| 2007-03-31 |
$11.76B |
$77.26B |
15.51% |
| 2006-12-31 |
$12.12B |
$76.90B |
16.05% |
| 2006-09-30 |
$13.03B |
$75.27B |
17.52% |
| 2006-06-30 |
$11.27B |
$73.94B |
15.32% |
| 2006-03-31 |
$11.26B |
$76.12B |
15.47% |
| 2005-12-31 |
$11.20B |
$72.11B |
15.49% |
| 2005-09-30 |
$12.08B |
$72.22B |
16.52% |
| 2005-06-30 |
$14.46B |
$70.85B |
19.49% |
| 2005-03-31 |
$15.07B |
$73.96B |
20.14% |
| 2004-12-31 |
$14.21B |
$75.56B |
18.84% |
| 2004-09-30 |
$12.68B |
$76.34B |
17.07% |
| 2004-06-30 |
$10.82B |
$73.47B |
14.63% |
| 2004-03-31 |
$3.94B |
$76.19B |
5.27% |
| 2003-12-31 |
$4.26B |
$71.13B |
6.76% |
| 2003-09-30 |
$5.56B |
$74.97B |
10.92% |
| 2003-06-30 |
$6.14B |
$76.99B |
16.30% |
| 2003-03-31 |
$12.02B |
$28.56B |
50.27% |
| 2002-12-31 |
$11.59B |
$23.09B |
51.91% |
| 2002-09-30 |
$10.45B |
$22.07B |
47.97% |
| 2002-06-30 |
$10.24B |
$21.90B |
47.62% |
| 2002-03-31 |
$10.32B |
$22.25B |
48.95% |
| 2001-12-31 |
$9.89B |
$20.90B |
48.41% |
| 2001-09-30 |
$7.92B |
$20.98B |
40.59% |
| 2001-06-30 |
$6.92B |
$20.18B |
37.20% |
| 2001-03-31 |
$5.99B |
$19.64B |
33.97% |
| 2000-12-31 |
$3.74B |
$17.20B |
24.27% |
| 2000-09-30 |
$4.82B |
$17.43B |
35.86% |
| 2000-06-30 |
$3.42B |
$16.24B |
29.96% |
| 2000-03-31 |
$3.02B |
$10.71B |
31.32% |
| 1999-12-31 |
$3.89B |
$9.41B |
41.49% |
| 1999-09-30 |
$3.90B |
$9.31B |
41.67% |
| 1999-06-30 |
$4.52B |
$9.18B |
48.57% |
| 1999-03-31 |
$3.91B |
$9.57B |
42.11% |
| 1998-12-31 |
$3.41B |
$9.34B |
37.36% |
| 1998-09-30 |
$2.41B |
$9.17B |
26.90% |
| 1998-06-30 |
$1.87B |
$9.03B |
21.48% |
| 1998-03-31 |
$1.69B |
$8.92B |
20.08% |
| 1997-12-31 |
$1.58B |
$8.66B |
19.41% |
| 1997-09-30 |
$1.79B |
$8.13B |
22.70% |
| 1997-06-30 |
$2.18B |
$7.91B |
28.58% |
| 1997-03-31 |
$2.54B |
$7.88B |
34.81% |
| 1996-12-31 |
$2.80B |
$7.64B |
40.35% |
| 1996-09-30 |
$2.83B |
$7.12B |
42.67% |
| 1996-06-30 |
$2.68B |
$6.57B |
42.90% |
| 1996-03-31 |
$2.50B |
$6.47B |
41.91% |
| 1995-12-31 |
$2.30B |
$6.34B |
40.46% |
| 1995-09-30 |
$2.25B |
$5.64B |
42.30% |
| 1995-06-30 |
$2.07B |
$5.44B |
40.56% |
| 1995-03-31 |
$2.01B |
$5.31B |
41.71% |
| 1994-12-31 |
$1.97B |
$4.93B |
42.90% |
| 1994-09-30 |
$1.88B |
$4.74B |
41.91% |
| 1994-06-30 |
$1.82B |
$4.32B |
41.39% |
| 1994-03-31 |
$1.74B |
$4.41B |
38.68% |
| 1993-12-31 |
$1.67B |
$4.44B |
35.73% |
| 1993-09-30 |
$1.62B |
$4.40B |
33.16% |
| 1993-06-30 |
$1.57B |
$4.78B |
29.70% |
| 1993-03-31 |
$1.52B |
$5.03B |
27.68% |
| 1992-12-31 |
$1.44B |
$5.29B |
25.53% |
| 1992-09-30 |
$1.35B |
$6.06B |
23.69% |
| 1992-06-30 |
$1.32B |
$5.62B |
24.05% |
| 1992-03-31 |
$1.29B |
$5.64B |
24.26% |
| 1991-12-31 |
$1.25B |
$5.42B |
23.91% |
| 1991-09-30 |
$1.20B |
$5.22B |
23.10% |
| 1991-06-30 |
$1.16B |
$4.99B |
22.28% |
| 1991-03-31 |
$1.12B |
$5.36B |
21.67% |
| 1990-12-31 |
$1.05B |
$5.29B |
20.79% |
| 1990-09-30 |
$1.02B |
$5.20B |
20.59% |
| 1990-06-30 |
$0.98B |
$4.86B |
20.38% |
| 1990-03-31 |
$0.95B |
$4.93B |
20.09% |
| 1989-12-31 |
$0.97B |
$4.73B |
20.72% |
| 1989-09-30 |
$0.97B |
$4.73B |
20.92% |
| 1989-06-30 |
$0.97B |
$4.53B |
21.30% |
| 1989-03-31 |
$1.05B |
$4.70B |
23.27% |
| 1988-12-31 |
$1.01B |
$4.53B |
22.79% |
| 1988-09-30 |
$1.01B |
$4.48B |
23.20% |
| 1988-06-30 |
$0.99B |
$4.37B |
23.46% |
| 1988-03-31 |
$0.99B |
$4.37B |
24.06% |
| 1987-12-31 |
$0.94B |
$4.13B |
23.60% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$201.199B |
$100.330B |
|
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
|
